\-\ Texto\\:\\ \ \(0\)\
\-\ due\\ to\\ the\\ size\\ of\\ the\\ mass\\ and\\ the\\ presentation\\ with\\ acute\\ hemorrhage\\,\\ treatment\\ was\\ indicated\\.\\ \\ the\\ patient\\ underwent\\ selective\\ catheter\\ based\\ embolization\\ of\\ the\\ lesion\\.\ \(0\)\
\-\ \\â\\€\\¢\\ contrast\\ enhanced\\ ct\\ of\\ the\\ abdomen\\ and\\ pelvis\\ demonstrates\\ a\\ large\\ enhancing\\ mass\\ in\\ the\\ left\\ kidney\\.\\ \\ the\\ mass\\ has\\ multiple\\ foci\\ of\\ fat\\ density\\.\\ \\ area\\ of\\ increased\\ density\\ within\\ the\\ mass\\ is\\ consistent\\ with\\ hemorrhage\\.\ \(0\)\
\-\ \\â\\€\\¢\\ catheter\\ angiogram\\ shows\\ large\\ mass\\ feed\\ by\\ interlobar\\ artery\\ with\\ prominent\\ neovascularity\\ and\\ delayed\\ washout\\.\ \(0\)\
\-\ \\â\\€\\¢\\ post\\-embolization\\ images\\ show\\ absent\\ flow\\ to\\ the\\ mass\\.\ \(0\)\
\-\ angiomyolipoma\ \(35\)\
\-\ \\â\\€\\¢\\ angiomyolipoma\ \(2\)\
\-\ \\â\\€\\¢\\ renal\\ cell\\ carcinoma\\ surrounding\\ renal\\ sinus\\ fat\ \(0\)\
\-\ 22\\ y\\/o\\ woman\\ presents\\ with\\ acute\\ left\\ sided\\ abdominal\\ pain\\.\ \(1\)\
\-\ this\\ woman\\ was\\ known\\ to\\ have\\ tuberous\\ sclerosis\\ \\(ts\\)\\.\\ \\ aml\\ occurs\\ in\\ a\\ majority\\ of\\ ts\\ patients\\,\\ though\\ often\\ small\\ and\\ uncomplicated\\.\\ \\ \ \(0\)\
\-\ symptoms\\ rarely\\ occur\\ in\\ patients\\ with\\ amls\\ less\\ than\\ 4cm\\ in\\ size\\.\\ \\ tumors\\ greater\\ than\\ 4cm\\ are\\ symptomatic\\ 80\\-90\\%\\ of\\ the\\ time\\ and\\ 50\\-60\\%\\ bleed\\ spontaneously\\.\ \(0\)\
\-\ embolization\\ of\\ angiomyolipomas\\ is\\ an\\ effective\\,\\ minimally\\ invasive\\ treatment\\.\\ \\ the\\ technical\\ success\\ rate\\ is\\ near\\ 100\\%\\.\\ \\ recurrence\\ \\(increase\\ in\\ size\\ \\>2cm\\ on\\ follow\\-up\\ imaging\\ and\\/or\\ recurrent\\ symptoms\\ requiring\\ repeat\\ embolization\\)\\ is\\ rare\\ in\\ sporadic\\ amls\\.\\ the\\ recurrence\\ rate\\ is\\ higher\\ in\\ patients\\ with\\ ts\\ and\\ lifelong\\ imaging\\ is\\ recommended\\.\\ \ \(0\)\
\-\ kothary\\ n\\,\\ soulen\\ mc\\,\\ clark\\ tw\\,\\ et\\ al\\.\\ renal\\ angiomyolipoma\\:\\ long\\-term\\ results\\ after\\ arterial\\ embolization\\.\\ \\ j\\ vasc\\ interv\\ radiol\\.\\ 2005\\;\\ 16\\:45\\-50\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ embolization\\:\\ 0\\.3103646879618241\ \(0\)\
\-\ ts\\:\\ 0\\.27785059671446866\ \(0\)\
\-\ angiomyolipoma\\:\\ 0\\.22856873629315466\ \(0\)\
\-\ amls\\:\\ 0\\.20036992072301102\ \(0\)\
\-\ the\\:\\ 0\\.1847519237292479\ \(0\)\
\-\ mass\\:\\ 0\\.16323305424138065\ \(0\)\
\-\ 4cm\\:\\ 0\\.1500545393766776\ \(0\)\
\-\ size\\:\\ 0\\.1446764252712371\ \(0\)\
\-\ renal\\:\\ 0\\.13305882134567512\ \(0\)\
\-\ catheter\\:\\ 0\\.12662443172872523\ \(0\)\
\-\ in\\:\\ 0\\.12402681925043357\ \(0\)\
\-\ patients\\:\\ 0\\.12020148931178885\ \(0\)\
\-\ recurrence\\:\\ 0\\.11760934565925382\ \(0\)\
\-\ is\\:\\ 0\\.11703037974643629\ \(0\)\
\-\ neovascularity\\:\\ 0\\.11390202160280224\ \(0\)\
\-\ of\\:\\ 0\\.11150512636018028\ \(0\)\
\-\ kothary\\:\\ 0\\.10883946243020146\ \(0\)\
\-\ soulen\\:\\ 0\\.10883946243020146\ \(0\)\
\-\ clark\\:\\ 0\\.10883946243020146\ \(0\)\
\-\ interv\\:\\ 0\\.10883946243020146\ \(0\)\
\-\ rate\\:\\ 0\\.107942434930029\ \(0\)\
\-\ vasc\\:\\ 0\\.1052475195341063\ \(0\)\
\-\ and\\:\\ 0\\.1030223763799432\ \(0\)\
\-\ interlobar\\:\\ 0\\.1024613921709323\ \(0\)\
\-\ tw\\:\\ 0\\.1024613921709323\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.09537195782758925\ \(0\)\
\-\ lifelong\\:\\ 0\\.0951224011889047\ \(0\)\
\-\ density\\:\\ 0\\.09445714437878269\ \(0\)\
\-\ feed\\:\\ 0\\.08960576262229099\ \(0\)\
\-\ technical\\:\\ 0\\.08960576262229099\ \(0\)\
\-\ fat\\:\\ 0\\.08861093167842063\ \(0\)\
\-\ angiomyolipomas\\:\\ 0\\.08793851539671442\ \(0\)\
\-\ radiol\\:\\ 0\\.08646789912020876\ \(0\)\
\-\ aml\\:\\ 0\\.08579282621873027\ \(0\)\
\-\ washout\\:\\ 0\\.0851523880335404\ \(0\)\
\-\ selective\\:\\ 0\\.08454320344969019\ \(0\)\
\-\ with\\:\\ 0\\.0836788129849577\ \(0\)\
\-\ sporadic\\:\\ 0\\.08095126055359504\ \(0\)\
\-\ than\\:\\ 0\\.08074925339453282\ \(0\)\
\-\ symptoms\\:\\ 0\\.07793902482823975\ \(0\)\
\-\ success\\:\\ 0\\.07713832415003433\ \(0\)\
\-\ acute\\:\\ 0\\.0770584754612779\ \(0\)\
\-\ imaging\\:\\ 0\\.07486081105170134\ \(0\)\
\-\ mc\\:\\ 0\\.07475284529623258\ \(0\)\
\-\ woman\\:\\ 0\\.07418695433978952\ \(0\)\
\-\ 2cm\\:\\ 0\\.07396400571047565\ \(0\)\
\-\ bleed\\:\\ 0\\.07298422424815518\ \(0\)\
\-\ effective\\:\\ 0\\.07275083787891204\ \(0\)\
\-\ spontaneously\\:\\ 0\\.07252173407092365\ \(0\)\
\-\ uncomplicated\\:\\ 0\\.0722967584848991\ \(0\)\
\-\ large\\:\\ 0\\.07137310558759973\ \(0\)\
\-\ tuberous\\:\\ 0\\.07102591938583323\ \(0\)\
\-\ requiring\\:\\ 0\\.07102591938583323\ \(0\)\
\-\ treatment\\:\\ 0\\.06785514780443812\ \(0\)\
\-\ 2005\\:\\ 0\\.06768827870631124\ \(0\)\
\-\ minimally\\:\\ 0\\.06753507669568895\ \(0\)\
\-\ invasive\\:\\ 0\\.06481000474618666\ \(0\)\
\-\ majority\\:\\ 0\\.06468819102665452\ \(0\)\
\-\ higher\\:\\ 0\\.06468819102665452\ \(0\)\
\-\ angiogram\\:\\ 0\\.06398125843140083\ \(0\)\
\-\ rarely\\:\\ 0\\.0635312707323994\ \(0\)\
\-\ repeat\\:\\ 0\\.062472517523088154\ \(0\)\
\-\ though\\:\\ 0\\.061877842885340276\ \(0\)\
\-\ arterial\\:\\ 0\\.0586542395976424\ \(0\)\
\-\ indicated\\:\\ 0\\.05857969724360235\ \(0\)\
\-\ absent\\:\\ 0\\.05843193448691749\ \(0\)\
\-\ 100\\:\\ 0\\.05843193448691749\ \(0\)\
\-\ foci\\:\\ 0\\.058213518295430915\ \(0\)\
\-\ near\\:\\ 0\\.05799885729670578\ \(0\)\
\-\ increase\\:\\ 0\\.05717531882650678\ \(0\)\
\-\ recurrent\\:\\ 0\\.0571090809670967\ \(0\)\
\-\ recommended\\:\\ 0\\.056655001573083764\ \(0\)\
\-\ al\\:\\ 0\\.05659146043230532\ \(0\)\
\-\ occurs\\:\\ 0\\.056155502677490705\ \(0\)\
\-\ prominent\\:\\ 0\\.056094447263818986\ \(0\)\
\-\ 22\\:\\ 0\\.056094447263818986\ \(0\)\
\-\ et\\:\\ 0\\.05579356988042834\ \(0\)\
\-\ delayed\\:\\ 0\\.0557342547702253\ \(0\)\
\-\ results\\:\\ 0\\.0554997726260711\ \(0\)\
\-\ symptomatic\\:\\ 0\\.054766760840041645\ \(0\)\
\-\ enhanced\\:\\ 0\\.05423080700697212\ \(0\)\
\-\ rare\\:\\ 0\\.053767363022993564\ \(0\)\
\-\ to\\:\\ 0\\.05341727080359299\ \(0\)\
\-\ greater\\:\\ 0\\.052472088257150204\ \(0\)\
\-\ occur\\:\\ 0\\.05238128198623988\ \(0\)\
\-\ tumors\\:\\ 0\\.05238128198623988\ \(0\)\
\-\ based\\:\\ 0\\.05159244240048296\ \(0\)\
\-\ sinus\\:\\ 0\\.05146568184759932\ \(0\)\
\-\ sclerosis\\:\\ 0\\.050731010707827526\ \(0\)\
\-\ kidney\\:\\ 0\\.05003717625929393\ \(0\)\
\-\ pelvis\\:\\ 0\\.049814209491102664\ \(0\)\
\-\ was\\:\\ 0\\.04964425068047962\ \(0\)\
\-\ underwent\\:\\ 0\\.04906376348225098\ \(0\)\
\-\ presentation\\:\\ 0\\.049029128765962354\ \(0\)\
\-\ left\\:\\ 0\\.04859183806788512\ \(0\)\
\-\ less\\:\\ 0\\.04845457889840076\ \(0\)\
\-\ surrounding\\:\\ 0\\.04750100060879477\ \(0\)\
\-\ flow\\:\\ 0\\.04743994519512305\ \(0\)\
\-\ often\\:\\ 0\\.04647338626625579\ \(0\)\
\-\ area\\:\\ 0\\.0461396699946843\ \(0\)\
\-\ known\\:\\ 0\\.046112258771345706\ \(0\)\
\-\ sided\\:\\ 0\\.04581464147497738\ \(0\)\
\-\ show\\:\\ 0\\.0452143721412138\ \(0\)\
\-\ enhancing\\:\\ 0\\.04461732738060081\ \(0\)\
\-\ artery\\:\\ 0\\.044234590678893335\ \(0\)\
\-\ abdomen\\:\\ 0\\.04345825758521003\ \(0\)\
\-\ carcinoma\\:\\ 0\\.0426027307435589\ \(0\)\
\-\ time\\:\\ 0\\.042216016316364756\ \(0\)\
\-\ shows\\:\\ 0\\.041802084247025355\ \(0\)\
\-\ due\\:\\ 0\\.040940652554369926\ \(0\)\
\-\ cell\\:\\ 0\\.04074317341351065\ \(0\)\
\-\ abdominal\\:\\ 0\\.038954069236868644\ \(0\)\
\-\ consistent\\:\\ 0\\.038619064069263256\ \(0\)\
\-\ increased\\:\\ 0\\.03851432930234129\ \(0\)\
\-\ small\\:\\ 0\\.03673952507442455\ \(0\)\
\-\ demonstrates\\:\\ 0\\.03578195579638252\ \(0\)\
\-\ have\\:\\ 0\\.03558008861019739\ \(0\)\
\-\ multiple\\:\\ 0\\.034837006687206996\ \(0\)\
\-\ contrast\\:\\ 0\\.03460608689387385\ \(0\)\
\-\ after\\:\\ 0\\.03455172978923206\ \(0\)\
\-\ presents\\:\\ 0\\.034262221933065315\ \(0\)\
\-\ lesion\\:\\ 0\\.03414617219236775\ \(0\)\
\-\ images\\:\\ 0\\.03294565097565942\ \(0\)\
\-\ within\\:\\ 0\\.03280338805548617\ \(0\)\
\-\ has\\:\\ 0\\.032532859423079506\ \(0\)\
\-\ by\\:\\ 0\\.03024566597406376\ \(0\)\
\-\ an\\:\\ 0\\.027235660726498138\ \(0\)\
\-\ ct\\:\\ 0\\.027115488410799735\ \(0\)\
\-\ are\\:\\ 0\\.02702611217221391\ \(0\)\
\-\ pain\\:\\ 0\\.025486420677634472\ \(0\)\
\-\ this\\:\\ 0\\.024473707247382473\ \(0\)\
\-\ patient\\:\\ 0\\.023165457462003887\ \(0\)\
\-\ on\\:\\ 0\\.021510745914891122\ \(0\)\
